| Title |
Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment
|
|---|---|
| Published in |
PLOS ONE, February 2009
|
| DOI | 10.1371/journal.pone.0004551 |
| Pubmed ID | |
| Authors |
Verena Ilona Carrara, Julien Zwang, Elizabeth A. Ashley, Ric N. Price, Kasia Stepniewska, Marion Barends, Alan Brockman, Tim Anderson, Rose McGready, Lucy Phaiphun, Stephane Proux, Michele van Vugt, Robert Hutagalung, Khin Maung Lwin, Aung Pyae Phyo, Piyanuch Preechapornkul, Mallika Imwong, Sasithon Pukrittayakamee, Pratap Singhasivanon, Nicholas J. White, François Nosten |
| Abstract |
Artemisinin combination treatments (ACT) are recommended as first line treatment for falciparum malaria throughout the malaria affected world. We reviewed the efficacy of a 3-day regimen of mefloquine and artesunate regimen (MAS(3)), over a 13 year period of continuous deployment as first-line treatment in camps for displaced persons and in clinics for migrant population along the Thai-Myanmar border. |
Mendeley readers
The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 3% |
| United Kingdom | 4 | 3% |
| Thailand | 3 | 2% |
| Brazil | 2 | 1% |
| France | 1 | <1% |
| Vietnam | 1 | <1% |
| Tanzania, United Republic of | 1 | <1% |
| Burkina Faso | 1 | <1% |
| Switzerland | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 128 | 86% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 30 | 20% |
| Student > Ph. D. Student | 21 | 14% |
| Student > Master | 14 | 9% |
| Other | 11 | 7% |
| Student > Bachelor | 9 | 6% |
| Other | 33 | 22% |
| Unknown | 30 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 36 | 24% |
| Medicine and Dentistry | 35 | 24% |
| Biochemistry, Genetics and Molecular Biology | 11 | 7% |
| Chemistry | 6 | 4% |
| Mathematics | 5 | 3% |
| Other | 21 | 14% |
| Unknown | 34 | 23% |